Molecular Residual Disease Assessment in a Representative Diverse Population of Patients With Early-stage Breast Cancer
Molecular Residual Disease Assessment in a Representative Diverse Population of Patients With Early-stage Breast Cancer
Recruiting · NCT07025785 · Registry updated 2026-09-02Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Molecular Residual Disease Assessment in a Representative Diverse Population of Patients With Early-stage Breast Cancer | Lymph Node Metastasis, Lymphatic Metastasis, Neoplasm Metastasis, Neoplasm, Residual, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Not applicable | 2026-09-02 | NCT07025785 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Haystack Oncology, Inc. | 4 |
| UNC Lineberger Comprehensive Cancer Center | 125 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| UNC Lineberger Comprehensive Cancer Center | Chapel Hill | United States | 9 |